ADME of monoclonal antibody biotherapeutics: knowledge gaps and emerging tools

ISSN： 1757-6199

Source： Bioanalysis, Vol.5, Iss.16, 2013-08, pp. : 2003-2014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab: a novel monoclonal antibody

By Keating Michael J O’Brien Susan Ferrajoli Alessandra

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody Protocols

By Jackson R.

Trends in Biochemical Sciences, Vol. 21, Iss. 7, 1996-07 ,pp. : 275-276

Elsevier

Access to resources Recommend Favorite

Monoclonal antibody treatments for rheumatoid arthritis

By Bossaller Lukas

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1257-1272

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody therapies for solid tumors

By Tassev Dimiter V Cheung Nai-Kong V

Expert Opinion on Biological Therapy, Vol. 9, Iss. 3, 2009-03 ,pp. : 341-353

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody-based therapeutics for leukemia

By Li Yiwen Zhu Zhenping

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 319-330

Informa Healthcare

Access to resources Recommend Favorite